https://www.healio.com/news/endocrinology/20230103/fda-approves-onceweekly-semaglutide-for-adolescents-with-obesity
0
0
1/3/23 at 7:40pm
Organization
Healio
55 words
0
Comments
The FDA approved once-weekly semaglutide for the treatment of obesity among adolescents aged 12 to 17 years with an initial BMI in the 95th percentile for age and sex, according to a press release.
The FDA’s new indication for semaglutide (Wegovy, Novo…
You are the first to view
Create an account
or login to join the discussion